Diabetes

A study found that certified diabetes educators embedded in a primary practice, while consulting with an endocrinologist, were able to dramatically improve A1C in a short time by overcoming clinical inertia.

This week, the top stories in managed care include news on how Medicaid expansion improved health outcomes of low-income individuals, a report on how physical activity lowers risk of 5 common chronic conditions, and findings on how insurance type impacts health outcomes in cancer.

Getting diabetes self-management education within reach of the target audience means putting trainers into primary care practices. A program from the University of Washington shows how to transport lessons from an academic center into local clinics.

The importance of care coordination and the role of diabetes educators in the primary care practice is a theme of the 2016 meeting of the American Association of Diabetes Educators, taking place in San Diego, California.

The authors note that employers dictate what Americans do for a large portion of the waking hours, and public health strategies to improve cardiovascular health could be targeted to certain job groups.

The findings of improved glycemic control but some incidence of diabetic ketoacidosis are consistent with other early findings of use of SGLT2 inhibitors in type 1 diabetes.

Adding more states and conditions to the Medicare Advantage value-based insurance design model will allow CMS to reach a more diverse group of plans and patients, in both rural and urban settings.

The institute is part of a planned development by Joseph Canizaro, who grew up in Biloxi and has transformed New Orleans' skyline over 4 decades.

Higher levels of activity were associated with a significantly lowered risk for outcomes in 5 common chronic diseases; however, the largest gains were made at lower levels of activity with diminishing gains as activity levels increased.

Medicaid expansion programs in Arkansas and Kentucky were found to be equally effective at improving healthcare access for the target population. Both programs face revisions following the election of Republican governors, who want to add work requirements.

The study reveals the importance of a taking a precision medicine approach to diabetes care.

What the proposed rules say about ensuring access to all Medicare beneficiaries who need to avoid diabetes.

While the online tools makes clear consumers can use it without obligation, the therapy section give patients information on AstraZeneca products.

Walking briskly on a regular basis may be more effective than vigorous jogging for improving glucose control in people with pre-diabetes, according to new research published in Diabetologia.

The findings support observations from an expert panel convened by The American Journal of Managed Care, who said patients lack awareness of the consequences of diabetes on their vision.

Both Express Scripts and CVS Health said they were taking aim at prescription drug prices that keep going up even when competitors are available.

Adrenal gland tumors that are defined as being nonfunctional may not really be so, and the hormones that these tumors secrete could increase an individual’s risk of cardiometabolic irregularities, according to a new study.

With Medicare preparing to reimburse for the Diabetes Prevention Program in January 2018, companies are forming or expanding to make this evidence-based program scalable to reach 86 million people with prediabetes.

Two consultants who help stakeholders in value-based transitions say CMS is serious about an aggressive pace for payment reform.

Experts say that at too many chain restaurants, individual meals exceed recommended calories for the entire day, to say nothing of excessive amounts of salt and fat.The Affordable Care Act will require most chains to put calorie counts on the menu by next year.

This week, the top stories in managed care included the release of Medicare's Star ratings for hospital quality, a new proposal from CMS to require bundled payments for cardiac care, and an FDA panel recommended approving a continuous glucose monitoring system for dosing insulin.

The work with mice models revealed how the functioning of a key receptor affects the body's ability to burn fat.

The study examined records for more than 124,000 people with type 2 diabetes over a 7-year period.

The approval paves the way for Sanofi's insulin and GLP-1 combination therapy, which is due for final FDA action in August.

The report found that in-person coaching and digital formats with human coaching were both effective and delivered value. ICER's review comes as Medicare is creating reimbursement standards to take effect in January 2018.